Taysha Gene Therapies
TSHA
₹231.35
Share price
0.75%
Change (1 day)
20.63%
Change (1 year)
Taysha Gene Therapies (TSHA) - P/B ratio
P/B ratio as of July 2025 : 12.7
According to Taysha Gene Therapies's latest financial reports the company has a price-to-book ratio of 96.6618.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Taysha Gene Therapies - P/B ratio (from 2020 to 2025)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2025-12-31 | N/A | -100% |
| 2024-12-31 | 5.01 | 13.55% |
| 2023-12-31 | 4.42 | -97.03% |
| 2022-12-31 | 149 | 3064.46% |
| 2021-12-31 | 4.70 | 17.83% |
| 2020-12-31 | 3.99 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 4.34 | -65.81% | 🇺🇸 USA |